Page last updated: 2024-10-30

losartan and Peritoneal Diseases

losartan has been researched along with Peritoneal Diseases in 1 studies

Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position

Peritoneal Diseases: Pathological processes involving the PERITONEUM.

Research Excerpts

ExcerptRelevanceReference
"Losartan suppressed the implant surface area of experimental endometriosis in rats and reduced the levels of plasma VEGF, TNF-α, PTX-3 and CRP."3.81Regression of experimental endometriotic implants in a rat model with the angiotensin II receptor blocker losartan. ( Ates, U; Cakmak, B; Cavusoglu, T; Erbaş, O; Meral, A; Nacar, MC, 2015)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cakmak, B1
Cavusoglu, T1
Ates, U1
Meral, A1
Nacar, MC1
Erbaş, O1

Other Studies

1 other study available for losartan and Peritoneal Diseases

ArticleYear
Regression of experimental endometriotic implants in a rat model with the angiotensin II receptor blocker losartan.
    The journal of obstetrics and gynaecology research, 2015, Volume: 41, Issue:4

    Topics: Angiotensin Receptor Antagonists; Animals; C-Reactive Protein; Cytokines; Disease Models, Animal; En

2015